ACRO Biomedical Total Debt vs. Price To Book

ACBM Stock  USD 0  0.00  0.00%   
Taking into consideration ACRO Biomedical's profitability measurements, ACRO Biomedical Co may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess ACRO Biomedical's ability to earn profits and add value for shareholders.
For ACRO Biomedical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of ACRO Biomedical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well ACRO Biomedical Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between ACRO Biomedical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of ACRO Biomedical Co over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between ACRO Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ACRO Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACRO Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

ACRO Biomedical Price To Book vs. Total Debt Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining ACRO Biomedical's current stock value. Our valuation model uses many indicators to compare ACRO Biomedical value to that of its competitors to determine the firm's financial worth.
ACRO Biomedical Co is the top company in total debt category among its peers. It also is number one stock in price to book category among its peers fabricating about  0.01  of Price To Book per Total Debt. The ratio of Total Debt to Price To Book for ACRO Biomedical Co is roughly  121.81 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ACRO Biomedical's earnings, one of the primary drivers of an investment's value.

ACRO Total Debt vs. Competition

ACRO Biomedical Co is the top company in total debt category among its peers. Total debt of Biotechnology industry is presently estimated at about 26.4 Million. ACRO Biomedical adds roughly 59,440 in total debt claiming only tiny portion of stocks in Biotechnology industry.
Total debt  Workforce  Valuation  Capitalization  Revenue

ACRO Price To Book vs. Total Debt

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

ACRO Biomedical

Total Debt

 = 

Bonds

+

Notes

 = 
59.44 K
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

ACRO Biomedical

P/B

 = 

MV Per Share

BV Per Share

 = 
487.98 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

ACRO Price To Book Comparison

ACRO Biomedical is currently under evaluation in price to book category among its peers.

ACRO Biomedical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in ACRO Biomedical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, ACRO Biomedical will eventually generate negative long term returns. The profitability progress is the general direction of ACRO Biomedical's change in net profit over the period of time. It can combine multiple indicators of ACRO Biomedical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana. Acro Biomedical operates under Biotechnology classification in the United States and is traded on OTC Exchange.

ACRO Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on ACRO Biomedical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of ACRO Biomedical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the ACRO Biomedical's important profitability drivers and their relationship over time.

Use ACRO Biomedical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ACRO Biomedical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACRO Biomedical will appreciate offsetting losses from the drop in the long position's value.

ACRO Biomedical Pair Trading

ACRO Biomedical Co Pair Trading Analysis

The ability to find closely correlated positions to ACRO Biomedical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ACRO Biomedical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ACRO Biomedical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ACRO Biomedical Co to buy it.
The correlation of ACRO Biomedical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ACRO Biomedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ACRO Biomedical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ACRO Biomedical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your ACRO Biomedical position

In addition to having ACRO Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Automobiles and Trucks Thematic Idea Now

Automobiles and Trucks
Automobiles and Trucks Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Automobiles and Trucks theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Automobiles and Trucks Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in ACRO Pink Sheet

To fully project ACRO Biomedical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of ACRO Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include ACRO Biomedical's income statement, its balance sheet, and the statement of cash flows.
Potential ACRO Biomedical investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although ACRO Biomedical investors may work on each financial statement separately, they are all related. The changes in ACRO Biomedical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ACRO Biomedical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.